NEW YORK (GenomeWeb News) - Mass spectrometry equipment maker Bruker BioSciences plans to offer for sale a total of 10.4 million shares of the company’s common stock.
The company said Friday that it has filed an S-3 statement with the US Securities and Exchange Commission and plans to offer up 2.2 million shares on its own. Four other shareholders, all members of the Laukien family, will offer an aggregate of 8.2 million shares, Bruker added. Both the company and the shareholders have granted underwriters 30 days to purchase an aggregate of as much as 1.6 million shares for over-allotments.
At midday today Bruker’s shares were trading down 6.5 percent at $7.42.